Large particle flow cytometry Large-particle flow cytometry was performed using a COPAS FP-250 flow cytometer (Union Biometrica, Holliston, MA) equipped with an automated sample introduction system, the LP Sampler, for 96-well plate analysis 106
If you want the broader landscape (and the list of other peptides driving search interest), see Metos internal piece: 14 Peptides Are About to Become Legal Again What This Means for Your Health. Who should consider AOD-9604 (and who shouldnt) Consider it only if your expectations are realistic AOD-9604 may be worth a conversation if you are: Already doing the fundamentals (protein, resistance training, sleep) Not seeking massive scale weight loss Looking at fat-loss support rather than appetite suppression Intolerant of GLP-1s and exploring alternatives (with the understanding that alternatives are usually less powerful) Avoid it if You have significant obesity and need a high-efficacy therapy (GLP-1/GIP class is typically far more impactful) (PubMed) Youre hoping it will melt fat without dietary alignment Your plan depends on unverified sources or research peptide suppliers Youre in a drug-tested sport environment (WADA prohibition is relevant) (wada-ama.org) Practical expectations (what most people want to know) How fast does it work
Compounded semaglutide belongs to the same class of drugs known as GLP-1 receptor agonists
For meaningful assessment of treatment response, standardized measurements should be employed, including limb circumference at defined anatomical points, validated pain scales, and quality-of-life instruments specific to lipedema or lymphatic conditions
